FOSTER CITY, Calif.--(BUSINESS WIRE)--Scientists from the Genome Institute of Singapore (GIS), a leading genome research institute, will use ultra-high throughput genomic analysis systems from Applied Biosystems Inc. (NYSE:ABI) to undertake a comprehensive analysis of the genetic changes that characterize cancer in humans. Applied Biosystems announced today that GIS will add three new SOLiD™ Systems to its existing base of genomics analysis technologies. With a total of four SOLiD Systems, GIS scientists plan to use these DNA sequencing platforms to expand their study of the genetic underpinnings of cancer and other complex human diseases.
